AU9293598A - The use of insulin-like growth factor-i in muscle - Google Patents

The use of insulin-like growth factor-i in muscle

Info

Publication number
AU9293598A
AU9293598A AU92935/98A AU9293598A AU9293598A AU 9293598 A AU9293598 A AU 9293598A AU 92935/98 A AU92935/98 A AU 92935/98A AU 9293598 A AU9293598 A AU 9293598A AU 9293598 A AU9293598 A AU 9293598A
Authority
AU
Australia
Prior art keywords
insulin
muscle
growth factor
growth
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU92935/98A
Inventor
Nadia A. Rosenthal
H. Lee Sweeney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
University of Pennsylvania Penn
Original Assignee
General Hospital Corp
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, University of Pennsylvania Penn filed Critical General Hospital Corp
Publication of AU9293598A publication Critical patent/AU9293598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU92935/98A 1997-08-25 1998-08-25 The use of insulin-like growth factor-i in muscle Abandoned AU9293598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5720197P 1997-08-25 1997-08-25
US60057201 1997-08-25
PCT/US1998/017428 WO1999010013A1 (en) 1997-08-25 1998-08-25 The use of insulin-like growth factor-i in muscle

Publications (1)

Publication Number Publication Date
AU9293598A true AU9293598A (en) 1999-03-16

Family

ID=22009122

Family Applications (1)

Application Number Title Priority Date Filing Date
AU92935/98A Abandoned AU9293598A (en) 1997-08-25 1998-08-25 The use of insulin-like growth factor-i in muscle

Country Status (2)

Country Link
AU (1) AU9293598A (en)
WO (1) WO1999010013A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923334D0 (en) * 1999-10-01 1999-12-08 Smithkline Beecham Plc Novel transgenic animal
ES2156769B1 (en) * 1999-11-26 2002-03-01 Univ Barcelona Autonoma CHEMERIC GEN THAT ALLOWS TO EXPRESS THE GENE OR THE CDNA OF THE SIMILAR GROWTH FACTOR TO TYPE I INSULIN (IGF-I) IN PANCREAS AND ITS USE FOR THE GENICAL THERAPY OF MELLITUS DIABETES.
GB0426154D0 (en) * 2004-11-29 2004-12-29 European Molecular Biology Lab Embl IGF-1 novel peptides
CA3209779A1 (en) 2021-02-01 2022-08-04 Regenxbio Inc. Gene therapy for neuronal ceroid lipofuscinoses
JP2024515184A (en) * 2021-04-19 2024-04-05 ヴェルサメブ アーゲー How to Treat Lower Urinary Tract Symptoms

Also Published As

Publication number Publication date
WO1999010013A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
AU2601895A (en) Modified insulin-like growth factors
AU2916195A (en) Marshmallow-type confections
AU1884797A (en) Improvements in or relating to contrast agents
AU4714797A (en) Improvements in or relating to contrast agents
AU1868595A (en) Human growth hormone
AU1434497A (en) Artificial muscle
AU4202097A (en) All natural ice-cream
AU5349298A (en) Flexible polyamide composition
AU3011497A (en) Novel human growth factors
AU4538297A (en) Inositolglycans having insulin-like action
AU6969498A (en) Skin cream composition
AU9293598A (en) The use of insulin-like growth factor-i in muscle
AU1384799A (en) Novel igf-i composition and its use
AUPO118896A0 (en) New use
AU8252498A (en) Skin cleaning composition
AU3118395A (en) Oligonucleotides and their use
AUPO440696A0 (en) New use
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
AU3085197A (en) Golfball
AU3031495A (en) Tee peg
AU8145598A (en) Cartilage growth agent
AU2419097A (en) Use of growth hormone
AUPP582198A0 (en) Modified human growth hormone
AU2953395A (en) Self-draining container
AU692233B2 (en) Aeration tank

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase